Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Stock Has Average Target Price of $16.40

Shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) have been assigned a consensus recommendation of “Buy” from the six research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $16.40.

A number of research analysts recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Lumexa Imaging in a research report on Tuesday, September 22nd. Truist Financial began coverage on shares of Lumexa Imaging in a research note on Monday, October 5th. They issued a “buy” rating and a $18.00 price target on the stock. Wall Street Zen raised shares of Lumexa Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, October 3rd. Raymond James Financial set a $17.00 price objective on shares of Lumexa Imaging in a research note on Monday, September 28th. Finally, KeyCorp began coverage on shares of Lumexa Imaging in a research note on Thursday, September 24th. They set an “overweight” rating and a $18.00 price objective for the company.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of LMRI. Jupiter Topco LLC bought a new stake in shares of Lumexa Imaging during the 2nd quarter worth approximately $24,269,000. BlackRock Inc. bought a new stake in Lumexa Imaging during the second quarter worth $15,771,000. Brigade Capital Management LP bought a new stake in Lumexa Imaging during the second quarter worth $7,511,000. Hunter Associates Investment Management LLC bought a new stake in Lumexa Imaging during the first quarter worth $1,231,000. Finally, Bank of America Corp DE lifted its stake in Lumexa Imaging by 1,855,116.7% in the first quarter. Bank of America Corp DE now owns 111,313 shares of the company’s stock valued at $957,000 after acquiring an additional 111,307 shares during the last quarter.

Lumexa Imaging Stock Down 0.6%

NASDAQ:LMRI opened at $11.67 on Friday. The company has a market cap of $1.12 billion and a P/E ratio of -23.82. Lumexa Imaging has a twelve month low of $6.45 and a twelve month high of $19.45. The business has a 50 day moving average price of $11.12 and a two-hundred day moving average price of $11.10.

Lumexa Imaging (NASDAQ:LMRI) last posted its quarterly earnings data on Wednesday, August 12th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.17. The business had revenue of $264.16 million during the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. As a group, analysts anticipate that Lumexa Imaging will post 0.25 earnings per share for the current fiscal year.

About Lumexa Imaging

Lumexa Imaging is a U.S.-based provider of outpatient diagnostic imaging and radiology services. The company operates imaging centers and offers services designed to support physicians, hospitals, health systems and patients in the diagnosis and monitoring of medical conditions.

Its service portfolio includes advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound and X-ray. Lumexa also provides radiology-related services, including image interpretation and support for referring healthcare providers, through fixed-site and mobile imaging operations.

The company serves communities across the United States through its network of outpatient facilities and healthcare partnerships.